Valuation: Qiagen N.V.

Capitalization 10.42B 8.91B 8.3B 7.72B 14.27B 894B 15.86B 99.47B 38.03B 419B 39.09B 38.29B 1,536B P/E ratio 2025 *
25.4x
P/E ratio 2026 * 22.9x
Enterprise value 10.82B 9.25B 8.62B 8.02B 14.81B 929B 16.46B 103B 39.49B 435B 40.59B 39.75B 1,595B EV / Sales 2025 *
5.24x
EV / Sales 2026 * 4.72x
Free-Float
97.04%
Yield 2025 *
0.1%
Yield 2026 * 0.1%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.87%
1 week-0.43%
Current month+0.15%
1 month+1.56%
3 months+14.65%
6 months+4.73%
Current year+5.08%
More quotes
1 week 47.24
Extreme 47.245
48.9
1 month 45.95
Extreme 45.95
48.9
Current year 37.63
Extreme 37.63
49.3
1 year 37.63
Extreme 37.63
49.3
3 years 36.84
Extreme 36.8377
54.27
5 years 36.84
Extreme 36.8377
62.56
10 years 21.96
Extreme 21.9573
62.56
More quotes
Manager TitleAgeSince
Chief Executive Officer 61 2019-10-06
Director of Finance/CFO 57 2003-12-31
Chief Operating Officer - 2022-03-31
Director TitleAgeSince
Director/Board Member 70 2003-12-31
Director/Board Member 76 2011-05-31
Director/Board Member 53 2015-12-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.87%-0.43%+10.94%-2.87% 10.42B
-0.95%+0.68%+8.88%+1.62% 50.02B
-1.22%+1.96%+64.49%+40.10% 29.65B
0.00%+0.34%+3.30%+8.18% 28.69B
-1.65%-0.88%-27.38%-23.76% 28.16B
-0.03%-0.39%+23.62%-20.18% 12.7B
-1.02%+0.28%-55.21%-27.95% 11.96B
-0.87%+0.45%+26.71%+94.27% 10.59B
-4.56%-6.71%+43.06% - 9.85B
-1.44%+0.62%-26.98%+113.01% 9.3B
Average -1.26%+0.30%+7.14%+20.27% 20.13B
Weighted average by Cap. -1.09%+0.69%+9.39%+11.82%
See all sector performances

Financials

2025 *2026 *
Net sales 2.07B 1.77B 1.65B 1.53B 2.83B 177B 3.14B 19.71B 7.54B 82.98B 7.75B 7.59B 304B 2.19B 1.88B 1.75B 1.63B 3B 188B 3.34B 20.94B 8.01B 88.16B 8.23B 8.06B 323B
Net income 426M 365M 340M 316M 584M 36.58B 649M 4.07B 1.56B 17.13B 1.6B 1.57B 62.83B 471M 403M 375M 349M 645M 40.43B 717M 4.5B 1.72B 18.93B 1.77B 1.73B 69.43B
Net Debt 399M 341M 318M 295M 546M 34.22B 607M 3.81B 1.46B 16.02B 1.5B 1.46B 58.76B -64.23M -54.92M -51.16M -47.58M -87.91M -5.51B -97.7M -613M -234M -2.58B -241M -236M -9.46B
More financial data * Estimated data
Logo Qiagen N.V.
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Employees
5,700
More about the company
Date Price Change Volume
25-07-11 48.13 $ -0.87% 2,421,661
25-07-10 48.55 $ +1.23% 1,179,544
25-07-09 47.96 $ +0.23% 1,750,884
25-07-08 47.85 $ +0.67% 1,755,876
25-07-07 47.53 $ -1.68% 1,083,029

Delayed Quote Nyse, July 11, 2025 at 04:00 pm EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
48.13USD
Average target price
50.42USD
Spread / Average Target
+4.76%
Consensus

Quarterly revenue - Rate of surprise